Understanding T cell immunity in adult T-cell leukemia/lymphoma
Functional state of CD8+ T cell immunity in adult T-cell leukemia/lymphoma
This study is looking at how the immune system, specifically certain T cells, reacts in people with adult T-cell leukemia/lymphoma (ATLL) in North America compared to Japan, with the goal of finding better treatments to help patients feel better.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project ID | NIH-11066547 on NIH RePORTER |
What this research studies
This research investigates the immune response of CD8+ T cells in patients with adult T-cell leukemia/lymphoma (ATLL), a severe condition linked to the human T-lymphotropic virus-1 (HTLV-1). The study aims to explore the differences in clinical presentation and immune characteristics between ATLL cases in North America and Japan. By enhancing our understanding of how ATLL cells evade the immune system, the research seeks to develop new therapeutic strategies that could improve patient outcomes. The approach includes examining the functional state of T cells and their ability to respond to the disease effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with adult T-cell leukemia/lymphoma, particularly those of Caribbean descent living in North America.
Not a fit: Patients with other types of leukemia or those not diagnosed with adult T-cell leukemia/lymphoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with adult T-cell leukemia/lymphoma.
How similar studies have performed: Previous research has shown promise in enhancing T cell responses in similar hematological malignancies, indicating potential for success in this area.
Where this research is happening
Bronx, United States
- Albert Einstein College of Medicine — Bronx, United States (Active)
Researchers
- Principal investigator: Ye, Bihui Hilda — Albert Einstein College of Medicine
- Study coordinator: Ye, Bihui Hilda
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.